These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 1079475)
1. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. Plunkett W; Cohen SS Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475 [TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture. Cass CE; Tan TH; Selner M Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin. Cass CE; Au-Yeung TH Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes. Bontemps F; Van den Berghe G Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493 [TBL] [Abstract][Full Text] [Related]
5. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes. Chang T; Glazko AJ Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646 [TBL] [Abstract][Full Text] [Related]
6. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes. Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516 [TBL] [Abstract][Full Text] [Related]
7. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts. Wilson JM; Mitchell BS; Daddona PE; Kelley WN J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901 [TBL] [Abstract][Full Text] [Related]
8. The utilization of nucleotides by animal cells. Cohen SS; Plunkett W Ann N Y Acad Sci; 1975 Aug; 255():269-86. PubMed ID: 1059361 [TBL] [Abstract][Full Text] [Related]
9. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase. Plunkett W; Cohen SS Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161 [No Abstract] [Full Text] [Related]
10. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. LePage GA; Worth LS; Kimball AP Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia. Lee SH; Caron N; Kimball AP Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931 [TBL] [Abstract][Full Text] [Related]
12. [Action of deoxyadenosine on nucleic acid synthesis by tumor cells in the presence of a deaminase inhibitor]. Vornovitskaia GI; Ioannesiants IA; Borzenko BG; Shapot VS Vopr Med Khim; 1975; 21(2):192-5. PubMed ID: 166514 [TBL] [Abstract][Full Text] [Related]
13. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. Carson DA; Seegmiller JE J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177 [TBL] [Abstract][Full Text] [Related]
14. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse. Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622 [TBL] [Abstract][Full Text] [Related]
15. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine. Smith SH; Shipman C; Drach JC Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine. Helland S; Ueland PM Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384 [TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3. Suling WJ; Rice LS; Shannon WM Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695 [No Abstract] [Full Text] [Related]
18. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained. Overgaard-Hansen K; Klenow H J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of adenosine deaminase and nucleoside transport. Utility in a model of homograft cardiac valve preimplantation processing. Abd-Elfattah AS; Messier RH; Domkowski PW; Jones JL; Aly HM; Crescenzo DG; Wallace RB; Hopkins RA J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1095-105. PubMed ID: 8501937 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole. Sato A; Montgomery JA; Cory JG Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]